Nass clinical evidence

Designed to prevent reherniation

Primary

A – Level 1 Meta Analysis

B – Intrinsic Level 1A FDA PMA RCT Study

C – RCT Study – Unsponsored

D – Intrinsic US Postmarket Confirmation of Effectiveness

Secondary

A – Intrinsic Sponsored Clinical Studies

B – Clinical Studies – Unsponsored

C – Intrinsic FDA PMA RCT Health Economics

D – Systemic Reviews

Preliminary Safety Data

i. Biomechanics

ii. Case Reports

iii. Health Economics – Other

iv. Perspectives

v. Letters to Editors

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin